BioTek Instruments has named Danny Luo as the new general manager of its China office.
BioTek Instruments has named Danny Luo as the new general manager of its China office. In a statement announcing Luo’s appointment, the company said that he is expected to grow and maintain the brand and revenues in the Chinese market, as well as spending his time liaising with the senior management to execute the company’s strategic plan, identify market requirements and emerging trends and optimize product and service levels in the Chinese market.
In the statement, Steven Fisher, managing director of the company’s Singapore branch said, "China is BioTek’s fastest growing and evolving market, and we needed a dynamic and market-proven leader to capitalize on this opportunity. Danny Luo’s excellent performance over the past few years made him the obvious choice for the position."
According to the company, Luo joined in 2006 as the marketing manager for China and Hong Kong, where he had responsibility for the local marketing and brand development. Since then he has also played a role in developing the company’s market presence in China and Hong Kong by introducing specialized collateral materials, actively driving channel development, and creating ongoing training and support systems for customers and distributors.